Cargando…

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Detalles Bibliográficos
Autores principales: Sanchis-Gomar, Fabian, Lavie, Carl J., Perez-Quilis, Carme, Henry, Brandon M., Lippi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241409/
https://www.ncbi.nlm.nih.gov/pubmed/32622458
http://dx.doi.org/10.1016/j.mayocp.2020.05.003
_version_ 1783537066576969728
author Sanchis-Gomar, Fabian
Lavie, Carl J.
Perez-Quilis, Carme
Henry, Brandon M.
Lippi, Giuseppe
author_facet Sanchis-Gomar, Fabian
Lavie, Carl J.
Perez-Quilis, Carme
Henry, Brandon M.
Lippi, Giuseppe
author_sort Sanchis-Gomar, Fabian
collection PubMed
description
format Online
Article
Text
id pubmed-7241409
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mayo Foundation for Medical Education and Research
record_format MEDLINE/PubMed
spelling pubmed-72414092020-05-21 In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Sanchis-Gomar, Fabian Lavie, Carl J. Perez-Quilis, Carme Henry, Brandon M. Lippi, Giuseppe Mayo Clin Proc Article Mayo Foundation for Medical Education and Research 2020-07 2020-05-21 /pmc/articles/PMC7241409/ /pubmed/32622458 http://dx.doi.org/10.1016/j.mayocp.2020.05.003 Text en © 2020 Mayo Foundation for Medical Education and Research. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sanchis-Gomar, Fabian
Lavie, Carl J.
Perez-Quilis, Carme
Henry, Brandon M.
Lippi, Giuseppe
In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_full In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_fullStr In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_full_unstemmed In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_short In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_sort in reply—angiotensin-converting enzyme 2 and the resolution of inflammation: in support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241409/
https://www.ncbi.nlm.nih.gov/pubmed/32622458
http://dx.doi.org/10.1016/j.mayocp.2020.05.003
work_keys_str_mv AT sanchisgomarfabian inreplyangiotensinconvertingenzyme2andtheresolutionofinflammationinsupportofcontinuationofprescribedangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockers
AT laviecarlj inreplyangiotensinconvertingenzyme2andtheresolutionofinflammationinsupportofcontinuationofprescribedangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockers
AT perezquiliscarme inreplyangiotensinconvertingenzyme2andtheresolutionofinflammationinsupportofcontinuationofprescribedangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockers
AT henrybrandonm inreplyangiotensinconvertingenzyme2andtheresolutionofinflammationinsupportofcontinuationofprescribedangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockers
AT lippigiuseppe inreplyangiotensinconvertingenzyme2andtheresolutionofinflammationinsupportofcontinuationofprescribedangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockers